Tarhini AA, Obermayer A, Lee SJ, LaFramboise WA, et al. Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-Risk Melanoma. Clin Cancer Res 2025 May 20. doi: 10.1158/1078-0432.CCR-24-3980.
PMID: 40392969